# Theophylline in Chronic Obstructive Pulmonary Disease

> **NCT00299858** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 24 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Theophylline

## Key facts

- **NCT ID:** NCT00299858
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299858, "Theophylline in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00299858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*